2019 annual financial data
Atossa Therapeutics 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,265,425 USD and net income was -17,239,777 USD.
Operating cash flow was -9,128,442 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,265,425 USD
- Net income
- -17,239,777 USD
- Operating cash flow
- -9,128,442 USD